KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Jul 16, 2020 $47.98 $49.31 $47.44 $49.02 768 000
Jul 15, 2020 $48.09 $48.75 $47.18 $48.18 894 200
Jul 14, 2020 $46.11 $47.39 $45.20 $47.34 1 459 300
Jul 13, 2020 $45.00 $48.97 $44.70 $46.13 1 816 600
Jul 10, 2020 $45.28 $45.85 $44.42 $44.51 721 900
Jul 09, 2020 $45.30 $46.27 $44.34 $45.15 1 034 800
Jul 08, 2020 $44.63 $45.31 $44.25 $45.25 746 500
Jul 07, 2020 $43.69 $45.72 $43.15 $44.24 926 300
Jul 06, 2020 $44.54 $45.16 $43.49 $43.72 816 900
Jul 02, 2020 $44.62 $45.20 $43.00 $44.20 945 967
Jul 01, 2020 $43.20 $44.80 $42.94 $44.16 1 244 504
Jun 30, 2020 $42.61 $43.41 $41.34 $43.19 965 088
Jun 29, 2020 $43.28 $43.54 $42.03 $42.60 1 086 429
Jun 26, 2020 $42.00 $43.84 $41.34 $43.27 2 091 402
Jun 25, 2020 $39.39 $42.39 $38.31 $42.23 1 230 268
Jun 24, 2020 $41.48 $42.21 $39.03 $39.76 1 342 070
Jun 23, 2020 $40.08 $42.97 $39.83 $41.76 2 064 473
Jun 22, 2020 $36.49 $40.02 $35.64 $39.83 1 401 209
Jun 19, 2020 $36.91 $37.14 $35.54 $36.73 2 739 314
Jun 18, 2020 $35.48 $37.62 $35.24 $36.72 947 399
Jun 17, 2020 $35.86 $36.24 $34.65 $35.51 975 259
Jun 16, 2020 $34.20 $36.17 $33.62 $35.75 1 158 448
Jun 15, 2020 $31.81 $33.58 $31.11 $33.22 961 535
Jun 12, 2020 $32.72 $32.79 $30.83 $32.73 1 104 910
Jun 11, 2020 $34.09 $34.19 $31.29 $31.58 1 407 468
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT